AVITA Medical Reports Decision on Say‑on‑Pay Vote Frequency

What Happened
AVITA Medical, Inc. (NASDAQ: RCEL) filed a Form 8‑K on August 6, 2026 (Accession No. 0001193125-26-338135) under Item 5.07 to report the submission of matters to a vote of security holders. The filing specifically discloses the Company’s decision regarding the frequency of future non‑binding stockholder advisory votes to approve the compensation of the Company’s named executive officers (the “say‑on‑pay” vote). The filing states no other changes were made to the Original Form 8‑K.

Key Details

• Filing date: August 6, 2026; Accession No.: 0001193125-26-338135.
• Form type: 8‑K, Item 5.07 — Submission of Matters to a Vote of Security Holders.
• Topic disclosed: the Company’s decision on how frequently it will conduct future advisory votes to approve named executive officers’ compensation (say‑on‑pay).
• The amendment notes there are no other changes to the original 8‑K filing.

Why It Matters
This disclosure informs investors about AVITA’s corporate governance schedule for shareholder consideration of executive pay. While say‑on‑pay votes are advisory (non‑binding), the chosen frequency (annual, biennial or triennial) affects how often shareholders can formally express approval or concern about executive compensation and can shape ongoing investor engagement and governance oversight.